Lab Notes: FDA to review Pfizer’s application for gene therapy licensed from Spark Therapeutics

This week’s Lab Notes has updates on a Spark-developed gene therapy candidate licensed to Pfizer, a laboratory equipment supplier’s new program to benefit the environment, some funding news for two local life sciences companies and more.
Click here to view original post